L. Baron, A. O. Paatero, J. D. Morel, F. Impens, L. Guenin-mace et al., Mycolactone subverts immunity by selectively blocking the sec61 translocon, J. Exp. Med, vol.213, pp.2885-2896, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01432024

D. Borsook, R. Hargreaves, C. Bountra, and F. Porreca, Lost but making progress-Where will new analgesic drugs come from?, Sci. Transl. Med, vol.6, pp.249-252, 2014.

P. J. Converse, Y. Xing, K. H. Kim, S. Tyagi, S. Y. Li et al., Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease, PLoS Negl. Trop. Dis, vol.8, 2014.

R. Cregg, G. Russo, A. Gubbay, R. Branford, and H. Sato, Pharmacogenetics of analgesic drugs, Br. J. Pain, vol.7, pp.189-208, 2013.

J. En, M. Goto, K. Nakanaga, M. Higashi, N. Ishii et al., Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study, Infect. Immun, vol.76, 2002.

K. M. George, D. Chatterjee, G. Gunawardana, D. Welty, J. Hayman et al., Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, Science, vol.283, pp.854-857, 1999.

M. Goto, K. Nakanaga, T. Aung, T. Hamada, N. Yamada et al., Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer, Am. J. Pathol, vol.168, pp.805-811, 2006.

L. Guenin-macé, L. Baron, A. C. Chany, C. Tresse, S. Saint-auret et al., Shaping mycolactone for therapeutic use against inflammatory disorders, Sci. Transl. Med, vol.7, pp.289-85, 2015.

B. Hall and R. Simmonds, Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in buruli ulcer, Biochem. Soc. Trans, vol.42, pp.177-183, 2014.

B. S. Hall, K. Hill, M. Mckenna, J. Ogbechi, S. High et al., The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER, PLoS Pathog, vol.10, p.1004061, 2014.

K. Hargreaves, R. Dubner, F. Brown, C. Flores, J. et al., A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, vol.32, pp.77-88, 1988.

H. Hong, P. J. Gates, J. Staunton, T. Stinear, S. T. Cole et al., Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulcerans, Chem. Commun, vol.21, pp.2822-2823, 2003.

C. Isaac, A. Mauborgne, A. Grimaldi, K. Ade, M. Pohl et al., Mycolactone displays anti-inflammatory effects on the nervous system, PLoS Negl. Trop. Dis, vol.11, p.6058, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01664214

P. D. Johnson, T. Stinear, P. L. Small, G. Pluschke, R. W. Merritt et al., Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control, PLoS Med, vol.2, p.108, 2005.

E. Marion, A. Chauty, M. Kempf, Y. Le-corre, Y. Delneste et al., Clinical features of spontaneous partial healing during Mycobacterium ulcerans infection, Open Forum Infect. Dis, vol.3, p.13, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01281366

E. Marion, U. Jarry, C. Cano, C. Savary, C. Beauvillain et al., FVB/N mice spontaneously heal ulcerative lesions induced by Mycobacterium ulcerans and switch M. ulcerans into a low mycolactone producer, J. Immunol, vol.196, pp.2690-2698, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01284881

E. Marion, S. Prado, C. Cano, J. Babonneau, S. Ghamrawi et al., Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage, PLoS One, vol.7, p.33600, 2012.

E. Marion, O. R. Song, T. Christophe, J. Babonneau, D. Fenistein et al., Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways, Cell, vol.157, pp.1565-1576, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01117565

L. Marsollier, G. Prevot, N. Honore, P. Legras, A. L. Manceau et al., Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin, Int. J. Antimicrob. Agents, vol.22, pp.240-241, 2003.

I. Melnikova, Pain market, Nat. Rev. Drug. Discov, vol.9, pp.589-590, 2010.

J. D. Morel, A. O. Paatero, J. Wei, J. W. Yewdell, L. Guenin-mace et al., Proteomics reveals scope of mycolactone-mediated sec61 blockade and distinctive stress signature, Mol. Cell. Proteo, vol.17, pp.1750-1765, 2018.

J. Ogbechi, B. S. Hall, T. Sbarrato, J. Taunton, A. E. Willis et al., Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4, Cell Death Dis, vol.3, pp.397-412, 2018.

F. S. Sarfo, P. J. Converse, D. V. Almeida, J. Zhang, C. Robinson et al., Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease, PLoS Negl. Trop. Dis, vol.7, p.2101, 2013.

F. S. Sarfo, F. Le-chevalier, N. Aka, R. O. Phillips, Y. Amoako et al., Mycolactone diffuses into the peripheral blood of buruli ulcer patients-implications for diagnosis and disease monitoring, PLoS Negl. Trop. Dis, vol.5, p.1237, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00691438

F. S. Sarfo, R. Phillips, M. Wansbrough-jones, and R. E. Simmonds, Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/buruli ulcer disease, Cell. Microbiol, vol.18, pp.17-29, 2016.

F. S. Sarfo, R. O. Phillips, J. Zhang, M. K. Abass, J. Abotsi et al., Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease, BMC Infect. Dis, vol.14, p.202, 2014.

T. H. Senanayake, Y. Lu, A. Bohling, S. Raja, M. H. Band et al., Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy, Pharm. Res, vol.31, pp.1605-1615, 2014.

V. Sizaire, F. Nackers, E. Comte, and F. Portaels, Mycobacterium ulcerans infection: control, diagnosis, and treatment, Lancet. Infect. Dis, vol.6, pp.288-296, 2006.

O. R. Song, H. B. Kim, S. Jouny, I. Ricard, A. Vandeputte et al., A bacterial toxin with analgesic properties: hyperpolarization of DRG neurons by mycolactone, Toxins, vol.9, p.227, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01582485

P. Stern and L. Roberts, The future of pain research, Science, vol.354, pp.564-565, 2016.

Q. B. Vincent, M. F. Ardant, A. Adeye, A. Goundote, J. P. Saint-andre et al., Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study, Lancet Glob. Health, vol.2, issue.14, pp.70223-70225, 2014.

, Conflict of Interest Statement: The authors declare that the research was

©. Copyright, . Babonneau, . Bréard, . Reynaert, . Marion et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, 2019.